Effective August 2, 2022, mdxhealth has acquired the Oncotype DX Genomic Prostate Score (GPS) test from Exact Sciences. Additionally, Genomic Health Inc, part of Exact Sciences, will continue to perform the GPS test during the transition. Further communications explaining transition plans will be provided in the coming months. For more details, please review the press release.
Questions? Email: gps@mdxhealth.com

Oncotype DX Breast DCIS Score® test

Choosing the right treatment for you

You’ve just been diagnosed with non-invasive stage 0 breast cancer (called ductal carcinoma in situ [DCIS]), so now what? There are many different treatment options to choose from, but how do you and your doctor know which one is right for you? Your doctor has ordered the DCIS Score® test to help you decide.

Watch this short video to see how the DCIS Score test has helped patients with non-invasive breast cancer choose the most appropriate treatment option for them.

You’ve just been diagnosed with non-invasive stage 0 breast cancer (called ductal carcinoma in situ [DCIS]), so now what? There are many different treatment options to choose from, but how do you and your doctor know which one is right for you? Your doctor has ordered the DCIS Score® test to help you decide.

Watch this short video to see how the DCIS Score test has helped patients with non-invasive breast cancer choose the most appropriate treatment option for them.

 

 

Which treatment is right for you? Your tumor knows

Just as every patient is different, so is every tumor. The DCIS Score test uses genomics to give you and your doctor important risk information about how your individual tumor will likely behave. And although DCIS is an early, non-invasive form of breast cancer—and rarely life threatening—the DCIS Score test provides valuable insights, including:

 

  • The 10-year risk of your tumor coming back in the same breast as another DCIS tumor
  • The 10-year risk of your cancer coming back as invasive breast cancer
  • Whether you may benefit from radiation therapy

 

 

Reasons to get the DCIS Score test:

Icon ribbon

It was the first clinically validated genomic test available for patients with DCIS

Tests show that tumors with similar clinical features do not necessarily have the same local recurrence risk.

Icon check

It can provide important insights into determining your treatment decisions

Your DCIS Score result predicts how likely your cancer is to return. Based on a very low score, you may feel comfortable avoiding aggressive surgery or radiation, or vice versa if your score is high.

Icon sand timer

It looks beyond traditional measures for insights into your tumor’s biology

Without the DCIS Score test, doctors can only estimate how likely your cancer is to return by looking at factors such as margin width, tumor size, and tumor grade.

Is the DCIS Score test right for you?

You may be a candidate for the breast DCIS Score test if you meet both of these criteria:

  • You’ve been recently diagnosed with DCIS and are making treatment decisions with your doctor
  • You’ve had a lumpectomy or biopsy
NOTE: If you’ve been diagnosed with stage I-IIIA invasive breast cancer, you may be eligible for the Oncotype DX Breast Recurrence Score® test.

Learn about the DCIS Score testing process

What you can expect from the DCIS Score results

In their own words: Stories  from patients with non-invasive DCIS breast cancer

See FAQs and videos  about the DCIS Score test

$0

financial responsibility for DCIS Score test when Medicare fee-for-service (FFS) coverage criteria are met

Medicare Advantage, which is provided by commercial insurance companies, may have different financial responsibility compared to Medicare FFS.

 

Learn about costs, coverage, and how Exact Sciences can help